- Home
- GPCR vs TBLA Comparison
GPCR vs TBLA Comparison
Compare GPCR & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- TBLA
- Stock Information
- Founded
- GPCR 2016
- TBLA 2007
- Country
- GPCR United States
- TBLA United States
- Employees
- GPCR N/A
- TBLA N/A
- Industry
- GPCR
- TBLA Computer Software: Programming Data Processing
- Sector
- GPCR
- TBLA Technology
- Exchange
- GPCR Nasdaq
- TBLA Nasdaq
- Market Cap
- GPCR 1.1B
- TBLA 1.2B
- IPO Year
- GPCR 2023
- TBLA N/A
- Fundamental
- Price
- GPCR $21.08
- TBLA $3.65
- Analyst Decision
- GPCR Strong Buy
- TBLA Strong Buy
- Analyst Count
- GPCR 7
- TBLA 4
- Target Price
- GPCR $76.17
- TBLA $4.50
- AVG Volume (30 Days)
- GPCR 844.3K
- TBLA 1.6M
- Earning Date
- GPCR 08-07-2025
- TBLA 08-06-2025
- Dividend Yield
- GPCR N/A
- TBLA N/A
- EPS Growth
- GPCR N/A
- TBLA N/A
- EPS
- GPCR N/A
- TBLA 0.04
- Revenue
- GPCR N/A
- TBLA $1,779,705,000.00
- Revenue This Year
- GPCR N/A
- TBLA $7.69
- Revenue Next Year
- GPCR N/A
- TBLA $6.15
- P/E Ratio
- GPCR N/A
- TBLA $91.10
- Revenue Growth
- GPCR N/A
- TBLA 16.63
- 52 Week Low
- GPCR $13.22
- TBLA $2.50
- 52 Week High
- GPCR $47.48
- TBLA $4.30
- Technical
- Relative Strength Index (RSI)
- GPCR 42.73
- TBLA 58.00
- Support Level
- GPCR $20.91
- TBLA $3.57
- Resistance Level
- GPCR $23.67
- TBLA $3.71
- Average True Range (ATR)
- GPCR 1.46
- TBLA 0.12
- MACD
- GPCR 0.04
- TBLA -0.01
- Stochastic Oscillator
- GPCR 21.43
- TBLA 70.59
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About TBLA Taboola.com Ltd.
Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, Germany, France, Rest of the world whilst it generates the majority of its revenue from the United States.